Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...
Earlier, Dr. Patni was Chief Medical Officer at Global Blood Therapeutics, Portola Pharmaceuticals, and Adamas Pharmaceuticals, until their acquisitions by larger companies. He also held roles of ...
Long-term data demonstrate that robust reductions and normalization in key biomarkers from baseline were maintained over time with continued ...
The merger is the second involving an SCD therapy developer in the last few weeks, coming after Pfizer agreed a $5.4 billion takeover of Global Blood Therapeutics and its oral therapy Oxbryta ...
Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...
Other potential takeover targets on the list are Global Blood Therapeutics ($2.2bn), Ultragenyx ($2.3bn), Sarepta ($4.8bn), OncoSec Medical ($100m), Mesoblast ($0.5bn), Acorda ($1.1bn), Sangamo ($ ...
Seoul National University Hospital announced on the 5th that it has been selected as the leading organization for the 'Global ...
Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and ...
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced the completion of enrollment in the explore-CKD phase 2 trial for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback